TABLE 3.
Multivariate analysis of risk factors associated with one-year disease control.
| Variables | HR | 95% CI | B-values* | p value** |
|---|---|---|---|---|
| BCLC stage | ||||
| B | 1 | |||
| C | 5.657 | 3.544–9.029 | 1.733 | <0.001 |
| Maximum tumor size (cm) | ||||
| ≤7 | 1 | |||
| >7 | 2.387 | 1.491–3.821 | 0.870 | <0.001 |
| AFP (ng/ml) | ||||
| ≤200 | 1 | |||
| >200 | 2.106 | 1.345–3.297 | 0.745 | 0.001 |
| ALBI grade | ||||
| 1 | 1 | |||
| 2 | 1.906 | 1.225–2.966 | 0.645 | 0.004 |
| No. of lesions | ||||
| 1 | 1 | |||
| >1 | 2.218 | 1.320–3.728 | 0.797 | 0.003 |
| Lobes involved | ||||
| Unilobar | 1 | |||
| Bilobar | 1.786 | 1.059–3.014 | 0.580 | 0.030 |
*
B-values are regression coefficients.
**
Multivariate logistic regression analysis was used. BCLC, Barcelona Clinic Liver Cancer; AFP, alpha-fetoprotein; ALBI, albumin–bilirubin.